|
|
|
|
Direct Cost |
Indirect Cost |
|
1DP2DE023321-01 |
Paving the Way for a Novel Therapeutic Approach to Combat HIV |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIDCR |
$1,500,000 |
$1,140,000 |
$2,640,000 |
1F31AI098424-01 |
Effect of Helicobacter pylori cell shape on pathogenesis |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIAID |
$34,690 |
|
$34,690 |
1F31GM101944-01 |
Regulatory Mechanisms and Biological Functions of non-coding RNA |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIGMS |
$35,644 |
|
$35,644 |
1F32DA033741-01A1 |
Anatomical and molecular characterization of appetite input to dopamine neurons |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIDA |
$55,670 |
|
$55,670 |
1F32ES021703-01 |
Dissecting the role of mitochondrial DNA mutations in cancer |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIEHS |
$52,190 |
|
$52,190 |
1F32GM103204-01 |
Chromosome nondisjuction and drive in hybrid meiosis. |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIGMS |
$52,190 |
|
$52,190 |
1K01DK090103-01A1 |
Shared Host Genetics and Bacterial Adaptation in the Transmission of H. pylori |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIDDK |
$92,685 |
$7,415 |
$100,100 |
1K08CA163603-01A1 |
Antibody directed delivery of short interfering RNA for the treatment of ovarian |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$157,992 |
$12,639 |
$170,631 |
1K08CA169014-01 |
Mechanisms of bHLH Mediated Lineage Specification |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$147,139 |
$11,771 |
$158,910 |
1K23AI097234-01A1 |
CMV Entry-Specific Neutralizing Antibody in Primary Infection in Transplantation |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIAID |
$121,000 |
$9,680 |
$130,680 |
1P50HL110787-01 |
Notch-Mediated Expansion of Cord Blood Progenitors for Stem Cell Transplant |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NHLBI |
$1,583,496 |
$1,087,125 |
$2,670,621 |
1R01AI094839-01A1 |
Elucidation of a bacterial cell shape generating program and pathogenic functions |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIAID |
$250,000 |
$173,554 |
$423,554 |
1R01AI101832-01 |
Discovering tissue-specific biomarkers of radiation injury in SILAC-labeled mice |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIAID |
$250,000 |
$190,000 |
$440,000 |
1R01CA158921-01A1 |
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$207,500 |
$157,700 |
$365,200 |
1R01CA160872-01A1 |
Discovery and Optimization of AML Prognostic Biomarkers |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$346,590 |
$250,706 |
$597,296 |
1R01CA161131-01A1 |
Weight Loss & Cancer Biomarkers in Women: 0xidative Stress & Inflammation |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$295,892 |
$135,440 |
$431,332 |
1R01CA165573-01 |
Resistance to Cancer Therapeutics Through Microenvironment Damage Responses. |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$207,500 |
$157,700 |
$365,200 |
1R01CA170122-01 |
Development of a comprehensive model for colorectal cancer risk prediction |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$220,411 |
$54,044 |
$274,455 |
1R01CA170386-01 |
Novel Pathogen Associated Cancers (PQ12) |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$537,072 |
$247,651 |
$784,723 |
1R01GM102198-01 |
Mapping epistasis in molecular evolution: the influenza nucleoprotein |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIGMS |
$190,000 |
$136,861 |
$326,861 |